| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MS-275 | FIMM | pan-cancer | AAC | 0.3 | 0.02 |
| mRNA | Dasatinib | GDSC1000 | pan-cancer | AAC | 0.12 | 0.02 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.071 | 0.02 |
| mRNA | B02 | CTRPv2 | pan-cancer | AAC | 0.091 | 0.02 |
| mRNA | IPA-3 | GDSC1000 | pan-cancer | AAC | 0.076 | 0.02 |
| mRNA | ZSTK474 | GDSC1000 | pan-cancer | AAC | 0.071 | 0.02 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | 0.11 | 0.02 |
| mRNA | YM-155 | GDSC1000 | pan-cancer | AAC | 0.076 | 0.02 |
| mRNA | lenvatinib | CTRPv2 | pan-cancer | AAC | 0.091 | 0.02 |
| mRNA | AA-COCF3 | CTRPv2 | pan-cancer | AAC | 0.089 | 0.02 |